Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Clinical trial NCT05615129 · COMPLETED
Trial details
- NCT number
- NCT05615129
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-08-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.